QUOTE AND NEWS
Marketwire  May 9  Comment 
NEW YORK, NY -- (Marketwire) -- 05/09/12 -- In recent months the Biotech Industry has become a hotbed of Merger and Acquisition (M&A) activity and speculation. As large pharmaceuticals face major patent expirations in 2012 they have looked to biotech
StreetInsider.com  May 2  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Geron+Corp+%28GERN%29+Tops+Q1+EPS+by+3c/7395906.html for the full story.
Marketwire  Apr 10  Comment 
NEW YORK, NY -- (Marketwire) -- 04/10/12 -- One major problems in recent years for emerging biotech companies has been funding for research. With the signing of the Jumpstart Our Business Startups (JOBS) Act emerging biotech stocks will be allowed
Benzinga  Mar 20  Comment 
Shares of Geron (NASDAQ: GERN) are lower on the session by 1.60%, currently trading at $1.84. The stock has been moving largely lower over the past three weeks, though it is currently testing the 50-day moving average. Options traders are...
Benzinga  Jan 17  Comment 
Shares of Geron (NASDAQ: GERN) are higher on the session by 2.37%, currently trading at $1.73. The stock has been moving largely higher over the past six weeks and is currently testing the 50-day moving average. Options traders are focusing on...
FierceBiotech  Jan 12  Comment 
As the global downturn squeezes the industry, all biotech companies are looking to make the most of their assets and rationalize their costs, and Geron is no different. The company has recruited St Louis-based broker Stifel Nicolaus to help it...
Benzinga  Jan 11  Comment 
View slider here. (c) 2011 Benzinga.com. All rights reserved. This material may not be published in its entirety or redistributed without the approval of Benzinga.
Benzinga  Jan 5  Comment 
Geron Corporation (Nasdaq: GERN) today announced the appointment of Graham Cooper as Executive Vice President, Finance and Business Development, and Chief Financial Officer. Mr. Cooper will provide direction for all financial matters for Geron and...
Marketwire  Nov 29  Comment 
NEW YORK, NY -- (Marketwire) -- 11/29/11 -- According to the World Health Organization, cancer will become the leading cause of death worldwide this year. Cancer has already emerged as the most expensive disease -- costing the global economy nearly a





You may also be interested in articles related to Geron (GERN):
 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki